Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-10

Clinical Trial Update: Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial update for Treximet in preventing post-traumatic headache with cognitive dysfunction; study terminated with posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Cady, Roger, M.D. | Conditions: Post-Traumatic Headache | Phase 4 | Status: TERMINATED | Results posted: 2014-03-10